Monoclonal antibody and purine analog

This page covers all Monoclonal antibody and purine analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD52.

Targets

CD52

Phase 2 pipeline (1)

• Alemtuzumab plus Fludarabine · Genzyme, a Sanofi Company · Oncology
  Alemtuzumab is a monoclonal antibody targeting CD52, a protein found on the surface of mature lymphocytes. Fludarabine is a purine analog that inhibits DNA synthesis.